These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 1604678)

  • 1. Comparison of intraperitoneal insulin infusion (using implantable pump) and subcutaneous insulin administration: preliminary results of a crossover study.
    Jeandidier N; Pinget M; Keipes M; Louy S; Vetter A; Réville P
    Transplant Proc; 1992 Jun; 24(3):948-9. PubMed ID: 1604678
    [No Abstract]   [Full Text] [Related]  

  • 2. One year continuous run with a totally implantable insulin infusion pump in a human diabetic.
    Mirouze J; Selam JL; Slingeneyer A; Chaptal PA; Franetzki M; Prestele K; Mion C
    Trans Am Soc Artif Intern Organs; 1983; 29():709-13. PubMed ID: 6369734
    [No Abstract]   [Full Text] [Related]  

  • 3. Is Pump Therapy for All with Type 1 Diabetes?
    Wilson DM
    Diabetes Technol Ther; 2016 May; 18(5):280-1. PubMed ID: 27159783
    [No Abstract]   [Full Text] [Related]  

  • 4. Randomized comparison of metabolic control achieved by intraperitoneal insulin infusion with implantable pumps versus intensive subcutaneous insulin therapy in type I diabetic patients.
    Selam JL; Raccah D; Jean-Didier N; Lozano JL; Waxman K; Charles MA
    Diabetes Care; 1992 Jan; 15(1):53-8. PubMed ID: 1737542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fasting and postprandial plasma glucose and peripheral insulin levels in insulin-dependent diabetes mellitus and non-insulin-dependent diabetes mellitus subjects during continuous intraperitoneal versus subcutaneous insulin delivery.
    Hermans MP; van Ypersele de Strihou M; Ketelslegers JM; Squifflet JP; Buysschaert M
    Transplant Proc; 1995 Dec; 27(6):3329-30. PubMed ID: 8539974
    [No Abstract]   [Full Text] [Related]  

  • 6. Implantable programmable insulin pumps for the treatment of diabetes.
    Waxman K; Turner D; Nguyen ST; Selam JL; Charles MA
    Arch Surg; 1992 Sep; 127(9):1032-6; discussion 1036-7. PubMed ID: 1387526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SHBG (sex hormone binding globulin) levels in insulin dependent diabetic patients according to the route of insulin administration.
    Lassmann-Vague V; Raccah D; Pugeat M; Bautrant D; Belicar P; Vague P
    Horm Metab Res; 1994 Sep; 26(9):436-7. PubMed ID: 7835829
    [No Abstract]   [Full Text] [Related]  

  • 8. [Metabolic control using a subcutaneous insulin infusion pump: effects 2 years after treatment].
    Goicolea Opacua I; Martínez Castillo A; Santamaría Pelarda E; Sola Sarabia C; Vázquez García JA
    Rev Clin Esp; 1988 Mar; 182(4):200-2. PubMed ID: 3045905
    [No Abstract]   [Full Text] [Related]  

  • 9. [Metabolic control in labile type I diabetes with conventional insulin therapy, basal bolus insulin therapy using pens and continuous subcutaneous insulin infusion with the pump].
    Biesenbach G; Grafinger P; Kaiser W; Stuby U; Zazgornik J
    Med Klin (Munich); 1988 May; 83(12):398-401. PubMed ID: 3043159
    [No Abstract]   [Full Text] [Related]  

  • 10. Long-term therapy of IDDM with an implantable insulin pump. The Implantable Insulin Pump Trial Study Group.
    Dunn FL; Nathan DM; Scavini M; Selam JL; Wingrove TG
    Diabetes Care; 1997 Jan; 20(1):59-63. PubMed ID: 9028695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized trial of continuous subcutaneous insulin infusion and intensive injection therapy in type 1 diabetes for patients with long-standing poor glycemic control.
    DeVries JH; Snoek FJ; Kostense PJ; Masurel N; Heine RJ;
    Diabetes Care; 2002 Nov; 25(11):2074-80. PubMed ID: 12401759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Continuous intraperitoneal insulin infusion versus subcutaneous insulin therapy in the treatment of type 1 diabetes: effects on glycemic variability.
    van Dijk PR; Groenier KH; DeVries JH; Gans RO; Kleefstra N; Bilo HJ; Logtenberg SJ
    Diabetes Technol Ther; 2015 Jun; 17(6):379-84. PubMed ID: 25856045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The suboptimal roadmap to the intensive therapy target.
    Davidson P; Hebblewhite H; Steed RD; Bode B
    Diabetes Technol Ther; 2004 Feb; 6(1):17-9. PubMed ID: 15000765
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison of continuous subcutaneous insulin infusion and multiple daily injection regimens in children with type 1 diabetes: a randomized open crossover trial.
    Weintrob N; Benzaquen H; Galatzer A; Shalitin S; Lazar L; Fayman G; Lilos P; Dickerman Z; Phillip M
    Pediatrics; 2003 Sep; 112(3 Pt 1):559-64. PubMed ID: 12949284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of multiple daily insulin therapy with continuous subcutaneous insulin infusion therapy in adolescents with type 1 diabetes mellitus: a single-center experience from Turkey.
    Abaci A; Atas A; Unuvar T; Demir K; Bober E; Büyükgebiz A
    J Pediatr Endocrinol Metab; 2009 Jun; 22(6):539-45. PubMed ID: 19694201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved glycemic control with intraperitoneal versus subcutaneous insulin in type 1 diabetes: a randomized controlled trial.
    Logtenberg SJ; Kleefstra N; Houweling ST; Groenier KH; Gans RO; van Ballegooie E; Bilo HJ
    Diabetes Care; 2009 Aug; 32(8):1372-7. PubMed ID: 19429874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term treatment of type I diabetes in 28 patients using two different implantable programmable pumps.
    Jeandidier N; Pinget M; Keipes M; Louy S; Charton MN; Marescaux J; Reville P
    Transplant Proc; 1992 Jun; 24(3):940-1. PubMed ID: 1604674
    [No Abstract]   [Full Text] [Related]  

  • 18. Both continuous subcutaneous insulin infusion and a multiple daily insulin injection regimen with glargine as basal insulin are equally better than traditional multiple daily insulin injection treatment.
    Lepore G; Dodesini AR; Nosari I; Trevisan R
    Diabetes Care; 2003 Apr; 26(4):1321-2. PubMed ID: 12663625
    [No Abstract]   [Full Text] [Related]  

  • 19. Assessment of use of specific features of subcutaneous insulin infusion systems and their relationship to metabolic control in patients with type 1 diabetes.
    Quirós C; Patrascioiu I; Giménez M; Vinagre I; Vidal M; Jansà M; Conget I
    Endocrinol Nutr; 2014; 61(6):318-22. PubMed ID: 24533929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sensor-augmented insulin-pump therapy in type 1 diabetes.
    Diamant M
    N Engl J Med; 2010 Nov; 363(21):2070; author reply 2071. PubMed ID: 21083396
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.